These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14677677)

  • 21. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
    Moonen P; Jacobs L; Crienen A; Dekker A
    Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
    Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
    Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus.
    Moonen P; van der Linde E; Chénard G; Dekker A
    Vet Microbiol; 2004 Apr; 99(2):93-101. PubMed ID: 15019100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foot-and-mouth disease polyvalent oil vaccines inoculated repeteadly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays.
    Espinoza AM; Maradei E; Mattion N; Cadenazzi G; Maddonni G; Robiolo B; La Torre J; Bellinzoni R; Smitsaart E
    Vaccine; 2004 Nov; 23(1):69-77. PubMed ID: 15519709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of antibodies to non-structural proteins of foot-and-mouth disease virus in repeatedly vaccinated cattle.
    Lee F; Jong MH; Yang DW
    Vet Microbiol; 2006 Jun; 115(1-3):14-20. PubMed ID: 16446061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
    Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses to foot-and-mouth disease virus in pig farms after the 1997 outbreak in Taiwan.
    Chen SP; Sun YF; Lee MC; Cheng IC; Yang PC; Huang TS; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vet Microbiol; 2008 Jan; 126(1-3):82-90. PubMed ID: 17716836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foot and mouth disease virus vaccines.
    Rodriguez LL; Grubman MJ
    Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
    Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
    Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals.
    Lu Z; Cao Y; Guo J; Qi S; Li D; Zhang Q; Ma J; Chang H; Liu Z; Liu X; Xie Q
    Vet Microbiol; 2007 Nov; 125(1-2):157-69. PubMed ID: 17601688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
    Kumar N; Sharma R; Kakker NK
    Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.
    Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N
    Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Past and present vaccine development strategies for the control of foot-and-mouth disease.
    Balamurugan V; Kumar RM; Suryanarayana VV
    Acta Virol; 2004; 48(4):201-14. PubMed ID: 15745043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.